JOHNSON CITY (Dec. 17, 2020) – Dr. Timir Paul of East Tennessee State University’s Quillen College of Medicine has received a $200,000 research grant from the University of Texas Southwestern to evaluate the “real world” effectiveness and use of non-stent and stent-based therapies among patients treated with peripheral artery disease.
Peripheral artery disease (PAD) is a narrowing of the peripheral arteries serving
the legs, stomach, arms and head. PAD most commonly affects arteries in the legs.
According to the American Heart Association, PAD affects over 8.5 million Americans
and over 200 million people worldwide.
This Multicenter Registry for Peripheral Arterial Disease Interventions and Outcome
(XL PAD Registry) involves approximately 14,000 patients at 60 sites nationwide. As
the local principal investigator for the grant, Paul will enroll data from approximately
1,000 patients.
The study will focus specifically on peripheral arterial endovascular intervention
and outcomes in the superficial femoral artery (leg artery) and below-the-knee artery
treatment of PAD.
“Although PAD is highly prevalent, there is no large national registry including all-comers
to evaluate long-term clinical events. This study will compare the effectiveness of
the different treatment strategies, namely stents vs non-stents-based techniques and
would shed light on the concept of ‘leaving nothing behind’ in the treatment of PAD
of the legs,” said Paul.
Paul currently serves as associate professor, director of Interventional Cardiology,
associate program director of Cardiology Fellowship and director of Cardiovascular
Research at Quillen College of Medicine. At ETSU Health, he is a full-time interventional
cardiologist.
In November 2020, Paul served as a moderator for the American Heart Association Scientific
Sessions. He was also elected as one of the Councilors for the American College of
Cardiology, Tennessee Chapter, for 2021-2023.
In addition, he is currently an institutional course director for the Emory Practical
Interventional Course-Southeastern Consortium and an academic editor for the PLOS
ONE journal.
To learn more about Quillen College of Medicine, visit www.etsu.edu/com.